Investor Malone Wealth Ventures LLC
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Malone Wealth Ventures LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-09-04 13G/A QNTM / Quantum BioPharma Ltd. 829,730 1,047,155
2025-07-18 13G/A QNTM / Quantum BioPharma Ltd. 735,148 829,730
2025-07-10 13G/A QNTM / Quantum BioPharma Ltd. 689,421 735,148
2025-07-10 13G/A QNTM / Quantum BioPharma Ltd. 689,421 689,421
2025-07-10 13G/A QNTM / Quantum BioPharma Ltd. 689,421 689,421
2025-06-30 13G/A QNTM / Quantum BioPharma Ltd. 610,371 689,421
2025-06-23 13D/A QNTM / Quantum BioPharma Ltd. 505,172 610,371
2025-06-23 13D/A QNTM / Quantum BioPharma Ltd. 505,172 580,806
2025-06-16 13D/A QNTM / Quantum BioPharma Ltd. 496,062 505,172
2025-06-12 13D QNTM / Quantum BioPharma Ltd. 447,848 496,062
2025-06-11 13G QNTM / Quantum BioPharma Ltd. 447,848